Immune profiling of advanced thyroid cancers using fluorescent multiplex immunohistochemistry.
CONCLUSIONS: Immune profiling revealed significant differences between advanced DTC and ATC, particularly in terms of PD-L1 expression and lymphocyte infiltration. Therefore, immune profiling using F-MIHC and MSI can provide invaluable information regarding tumor microenvironments, which could help select candidates for immunotherapy.
PMID: 32611231 [PubMed - as supplied by publisher]
Source: Thyroid : official journal of the American Thyroid Association - Category: Endocrinology Tags: Thyroid Source Type: research
More News: Cancer | Cancer & Oncology | Carcinoma | Endocrinology | Immunotherapy | Study | Thyroid | Thyroid Cancer